Drugs and biologics hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.

Drugs and biologics [electronic resource] : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, May 25, 1995-a consumer's perspective, June 19, 1995-FDA review process.

Show other versions (1)
Saved in:
Bibliographic Details
Online Access: Full Text (via ProQuest)
Corporate Author: United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations
Format: Government Document Electronic eBook
Language:English
Published: Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995.
Subjects:
United States. > Food and Drug Administration.
Drugs > Bioavailability > United States.
Drugs > Testing > Health aspects > United States.
Drugs > Testing > Economic aspects > United States.

Internet

Full Text (via ProQuest)

Online

Holdings details from Online
Call Number: HRG-1995-COH-0010
HRG-1995-COH-0010 Available

Similar Items